28 Analytical Validation of a Novel Point-of-Care Coagulometer for DOAC and Heparin Testing
Sasha Bakhru(Sphere Institute), Jack Ansell(Hofstra University), L. Chen(Hofstra University), Stefan Zappe(Hofstra University), Xiaoying Jiang(Hangzhou Normal University), Y. Wang(Hofstra University), Dugagjin Osmani(Hofstra University), Daryl Mootoo(Hofstra University)
Cited by 0
Related Papers
Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors
|American Journal of Hematology|2012|366
Guidance for the treatment of deep vein thrombosis and pulmonary embolism
|Journal of Thrombosis and Thrombolysis|2016|343
Natural terpenoids with anti-inflammatory activities: Potential leads for anti-inflammatory drug discovery
|Bioorganic Chemistry|2022|172
Outcomes registry for better informed treatment of atrial fibrillation: Rationale and design of ORBIT-AF
|American Heart Journal|2011|147
Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum
|Annals of Pharmacotherapy|2008|105